Teleflex Inc TFX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Teleflex to Present at the Jefferies Global Healthcare Conference in London
Teleflex Announces Quarterly Dividend
Teleflex Reports Third Quarter Financial Results and Full Year 2026 Outlook
Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
Trading Information
- Previous Close Price
- $157.10
- Day Range
- $155.70–161.00
- 52-Week Range
- $100.18–161.00
- Bid/Ask
- $127.66 / $160.73
- Shares Outstanding
- 39.66M
- Market Cap
- $6.33B
- Volume/Avg
- 2M / 757,091
Key Statistics
- Price/Earnings (Normalized)
- 18.23
- Price/Sales
- 4.12
- Dividend Yield (Trailing)
- 0.85%
- Dividend Yield (Forward)
- 0.85%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 9.62%
Company Profile
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 15,500
- Website
- https://www.teleflex.com
Valuation
Metric | TFX |
|---|---|
Price/Earnings (Normalized) | 18.23 |
Price/Book Value | 1.94 |
Price/Sales | 4.12 |
Price/Cash Flow | — |
Price/Earnings
TFX
Financial Strength
Metric | TFX |
|---|---|
Quick Ratio | 0.88 |
Current Ratio | 2.01 |
Interest Coverage | 2.02 |
Quick Ratio
TFX
Profitability
Metric | TFX |
|---|---|
Return on Assets (Normalized) | 3.26% |
Return on Equity (Normalized) | 6.88% |
Return on Invested Capital (Normalized) | 5.16% |
Return on Assets
TFX
Medical Instruments & Supplies Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc ISRG | LOCK|%^<W&g? | LOCK|q> | $149B | |||
| Becton Dickinson & Co BDX | LOCK|Vc | LOCK|^!P%L | $59B | |||
| Alcon Inc ALC | LOCK|m@wSL% | LOCK|%dp% | $35B | |||
| ResMed Inc RMD | LOCK|%Q$?K&% | LOCK|xv@f? | $33B | |||
| Medline Inc Ordinary Shares - Class A MDLN | LOCK|lC<>>? | LOCK|b!z# | $33B | |||
| West Pharmaceutical Services Inc WST | LOCK|N$^&sN^v | LOCK|MJ | $29B | |||
| Solventum Corp SOLV | LOCK|MQ#?$z | LOCK|rz | $15B | |||
| Baxter International Inc BAX | LOCK|&#> | LOCK|!?gX | $13B | |||
| The Cooper Companies Inc COO | LOCK|z!LC>P^ | LOCK|Yf@n | $12B | |||
| Align Technology Inc ALGN | LOCK|y%F?XSk | LOCK|n%%& | $12B |